Our Investors

To achieve our ambitious strategy to become a leading biotech company in the development of single-strain keystone biotherapies, we are open to welcome new investors.

Established in 2010, YSOPIA Bioscience has already raised €22.7M.

> Discover our pipeline

Key facts:

We are backed by renowned and valuable investors.

Seventure Partners / Health For Life Capital, Europe’s leading microbiome innovation investment fund, is our historic lead investor.

Three family offices have also backed YSOPIA Bioscience, as well as public investors, including the Nouvelle Aquitaine region. We also received support from BPI France.

Want to talk to our CEO?

Microbiome & us
Jun 1, 2021
90 seconds to learn more about YSOPIA Bioscience | [playlist type="video" ids="2641"]
> more
May 4, 2021
We are looking for a Senior Scientist in Microbiology & Biotechnology – Team Leader position | WHAT WE...
> more
Press / Media
May 24, 2021
Sur un marché mondial estimé à deux milliards de dollars d’ici à 2030, la filière du microbiome pharma veut...
> more
Mar 4, 2021
Read the full article    
> more
Jun 1, 2021
Camille Kropp, Katy Le Corf, Karima Relizani, Kevin Tambosco, Ccori Martinez, Florian Chain, Georges Rawadi, Philippe...
> more
Apr 6, 2021
Mazier W., Le Corf K., Martinez C., Tudela H., Kissi D., Kropp C., Coubard C., Soto M., Elustondo F., Rawadi G., Claus...
> more
now on twitter
YSOPIA Bioscience

A pilot #study led by Professor Phillip Popovich has placed focus on how traumatic spinal cord injuries might impac…

YSOPIA Bioscience © 2021 - all rights reserved terms and conditions